Skip to main content
. 2011 Feb 18;7(3):305–324. doi: 10.1007/s11302-011-9216-0

Fig. 2.

Fig. 2

Thienopyridines as non-nucleotide antagonists of the P2Y12 receptor that require activation in vivo. Enzymatic formation of the active metabolites precedes the formation of the disulfide bond with the target P2Y12 receptor on platelets. CYP=cytochrome P450